ASCAHIFA and Biosfer Teslab on Familial Hypercholesterolemia Day
ASCAHIFA and Biosfer Teslab join forces to advance the diagnosis of familial hypercholesterolemia with Liposcale® On September 24, we celebrate Familial Hypercholesterolemia (FH) Day, a hereditary genetic condition that causes very high levels of LDL cholesterol from birth and greatly increases the risk of developing premature cardiovascular disease. It is estimated that FH affects 1 […]
When LDL Cholesterol Doesn’t Tell the Whole Story: A Clinical Case of Hidden Cardiovascular Risk
The Challenge of Residual Risk in Cardiovascular Health Cardiovascular diseases remain the leading cause of death worldwide.Despite preventive efforts—such as controlling LDL cholesterol, blood pressure, and glucose levels—many individuals still suffer heart attacks or strokes even with apparently “normal” values. This phenomenon is known as residual cardiovascular risk, and it accounts for up to 60–70% […]
NMR Metabolomics in Animal Models: A Key Tool for Translational Research
In biomedical research, animal models represent a fundamental tool for understanding the pathophysiological mechanisms of human diseases and for exploring new therapeutic strategies. They allow for the controlled reproduction of complex clinical conditions, the study of disease progression—particularly in chronic or metabolic disorders—and the evaluation of interventions before their application in humans. In […]
Liposcale and Glycoscale in Cardiovascular Risk Prediction in Type 2 Diabetes
Each year, cardiovascular diseases (CVD) are responsible for more than 4 million deaths in Europe, making them the leading cause of mortality on the continent. These diseases include heart attacks, strokes, and other conditions related to the circulatory system. For decades, the prevention and treatment of CVD have focused on lowering LDL cholesterol (commonly known as “bad […]
Beyond LDL: A Comprehensive Approach to Cardiovascular Health
Each year, cardiovascular diseases (CVD) are responsible for more than 4 million deaths in Europe, making them the leading cause of mortality on the continent. These diseases include heart attacks, strokes, and other conditions related to the circulatory system. For decades, the prevention and treatment of CVD have focused on lowering LDL cholesterol (commonly known as “bad […]
Ketone bodies and their potential as biomarkers in relapsed/refractory diffuse large B-cell lymphoma
New Findings in DLBCL Research Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. While most patients respond favorably to initial treatment, a significant percentage develop relapsed or refractory (R/R) disease, which limits therapeutic options and worsens prognosis. A recent study published in the journal Cancers has identified two […]
H-NMR Metabolomics: A New Perspective for Classifying Obesity and Predicting Cardiometabolic Risks
Obesity, a complex and multifactorial disease, currently affects more than 13% of adults worldwide, according to the latest data from the World Health Organization (WHO). This alarming increase, which has reached epidemic proportions in recent decades, highlights the urgent need for innovative and effective approaches to better understand and manage this condition. Traditionally, […]
Expanding into International Markets with the Support of ACCIÓ
We Drive Our International Expansion with the Support of ACCIÓ At Biosfer Teslab, we continue to expand our international presence thanks to the support of ACCIÓ, which has enabled us to drive growth and consolidate the Liposcale® test in new markets. Through the grant for international promotion activities, we have developed innovative digital tools that […]
Exploring New Frontiers in Biomarker Analysis: NMR in Multiple Biological Matrices
Nuclear magnetic resonance (NMR) is an advanced technology that allows the analysis of various biological matrices, from blood and urine to less conventional bodily fluids such as breast milk. This ability to explore different matrices with a single analytical approach makes it highly applicable for early disease detection and monitoring specific conditions, adapting […]
The XXVI Jornadas of XULA
The XXVI Jornadas of XULA (Xarxa d’Unitats de Lípids i Arteriosclerosi) are much more than just a scientific gathering. It is a space for exchange, where healthcare professionals, researchers, and experts in lipidology and atherosclerosis come together to discuss the latest advances in the treatment and prevention of cardiovascular diseases. “The Jornadas” This […]
